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Previous research using -fetoprotein knockout and aromatase knockout (ArKO) female mice
suggested that the developing hypothalamic mechanisms that later control feminine sexual be-
havior are protected prenatally fromestradiol, whereas shortly after birth, theymay be stimulated
by this same sex hormone. In the present study, we found that the amount of progesterone
receptor immunoreactivity (PR-ir) in the anteroventral periventricular nucleus and medial part of
the medial preoptic nucleus was significantly lower in ArKO female mice than in wild-type (WT)
females at several prepubertal ages including postnatal d 15 (P15), P15, P20, and P25 but not
neonatally at P0, P5, or P10. Likewise, PR-ir in the lateral subdivision of the ventromedial hypo-
thalamic nucleus was significantly lower at P25 in ArKO vs. WT female mice but not at earlier
postnatal ages. PR-ir was consistently higher in male than in female WTmice in the anteroventral
periventricular nucleus and medial preoptic nucleus over P0–P10 and in the ventromedial hypo-
thalamic nucleus over P0–P20. In these brain regions across these latter ages, PR-ir in male ArKO
mice was significantly lower than in WT males and resembled the values seen in WT females,
confirming previous reports that estradiol formed in the developing male hypothalamus from
testicular testosterone is responsible formale-typical levels of neural PR expression. Thus, estradiol
induces both female- and male-typical expression of PR postnatally in the mouse hypothalamus.
Future experimentswill determinewhether this estradiol-induced PR expression contributes to
either female- or male-typical brain and behavioral differentiation. (Endocrinology 151:
1814–1821, 2010)
A central tenet of contemporary theories of mamma-lian brain and behavioral sexual differentiation is
that an organizational action of testosterone, secreted
perinatally by the male’s testes, controls male-typical fac-
ets of brain and behavioral development, whereas no
active perinatal sex hormone signaling is required for
female-typical differentiation. In rodents (1) and carnivores
(2),much evidence suggests thatmany, althoughnot all, of
the perinatal organizational actions of testosterone on
male nervous system development actually result from the
cellular effects of estradiol formed via the local, neural
aromatization of circulating testosterone. It was proposed
many years ago (3) that the brain of the developing female
rodent fetus is protected from the actions of maternal es-
tradiol and/or from aromatized products of testosterone
derived from adjacent male fetuses by the relatively high-
affinity binding of this sex hormone by circulating -fe-
toprotein (AFP). Indeed, Bakker et al. (4) found that the
capacity ofAFP-nullmutant [AFP-knockout (KO)] female
mice to display feminine receptive sexual behavior (lor-
dosis) after adult ovariectomy and treatment with estra-
diol plus progesterone was severely attenuated. Likewise,
AFP-KO females had a male-like number of tyrosine hy-
droxylase immunoreactive (ir) cells in the sexually differ-
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entiated anteroventral periventricular nucleus (AVPv) of
the hypothalamus. Both of these behavioral and morpho-
logical consequences of the AFP-null mutation in female
mice were reversed by transplacental treatment with an
aromatase-inhibiting drug, 1,4,-androstatriene-3,17-di-
one (ATD). These results provide evidence that circulating
AFP binds circulating estradiol in female fetuses so as to
protect their brains from the potential defeminizing ac-
tions of this hormone that otherwise normally occur in the
male nervous system in response to estradiol synthesized
from testosterone after it is taken up from the circulation.
Toran-Allerand (5) first proposed that estradiol may
actively contribute to the differentiation of female-typical
aspects of brain and behavioral sexual differentiation.
Early studies (6, 7) reported that removing the ovaries
neonatally from female rats reduced their later lordotic
responsiveness to ovarian hormones and that treatment
with estradiol over peripubertal ages reversed the behav-
ioral deficits induced by neonatal ovariectomy. More re-
cently (8, 9), it was proposed that different doses of genes
expressed off the X chromosome in XY (male) vs. XX
(female) mice influence aspects of brain and behavioral
sexual differentiation, perhaps reflecting a nonhormonal,
genetic signaling mechanism that actively promotes
female-typical brain sexual differentiation. Additional ev-
idence of a possible contribution of estradiol to female-
typical behavioral development involved the report (10)
that aromatase-KO (ArKO) female mice showed signifi-
cantly lower levels of lordosis behavior than wild-type
(WT) controls after adult ovariectomy and treatmentwith
ovarian hormones. ArKO females also showed signifi-
cantly lower levels of olfactory investigation of urinary
odors frommale and female conspecifics and significantly
less male-like mounting behavior toward a stimulus
female than WT females. Finally, ArKO females had sig-
nificantly fewer kisspeptin neurons than WT females in
theAVPv (11). These results have resurrected the question
of whether estradiol, acting during the first several weeks
of life, actively contributes to female-typical brain and
behavioral sexual differentiation (12), perhaps beginning
after postnatal d 7 (P7) when the rat ovary first produces
estradiol (13).
One approach to the question of whether estradiol ac-
tively contributes to female-typical brain sexual differen-
tiation would be to compare the postnatal neural expres-
sion of an estradiol-dependent gene in ArKO female mice,
which produce no estradiol in any tissue, and in WT con-
trol females. The expressionof progesterone receptor (PR)
in the hypothalamusof adult female rodents iswell known
tobedramaticallyup-regulatedbyestradiol (14,15).Like-
wise, Wagner and co-workers have conducted an exten-
sive series of experiments showing that the number of
PR-ir cells in themedial preoptic area (MPOA), the lateral
part of the ventromedial hypothalamic nucleus (VMH-L),
and AVPv of both rat (16) and mouse (17, 18) is signifi-
cantly greater in neonatal males than in females. Addi-
tional work from this group (18, 19) showed that estra-
diol, formed via the neural aromatization of testosterone
in male neonates, is responsible for the higher, male-typ-
ical levels of PR expression in theMPOA. Finally, another
study from this group (20) found that transplacental ad-
ministration of the aromatase blocker ATD significantly
reduced PR-ir in theMPOAof female rats killed at the end
of gestation. Based on these results, we sought to use the
expression of PR in three different hypothalamic regions,
AVPv, MPOA, and VMH-L, as an index of estradiol’s
action in the female mouse brain across the first 25 d of
postnatal development.We predicted that if estradiol nor-
mally acts in the developing female mouse hypothalamus,
wewould see significantly less PR-ir in some or all of these
three brain regions from ArKO females (which cannot
synthesize estradiol) vs. WT females at one or several of
the postnatal ages studied. Finally, to confirm that our
method of monitoring PR-ir in postnatal hypothalamic
regions was reliable, we analyzed PR-ir in the same hypo-
thalamic regions and at the same postnatal ages in WT
males in an attempt to replicate the previous reports of
Wagner et al. (21) of a sex difference in hypothalamic
expression of PR shortly after birth.We also added groups
of ArKO males to further test the hypothesis (15) that
estrogenic metabolites of testosterone, formed in the male
hypothalamus, stimulate the high, male-typical levels of
neonatal PR expression.
Materials and Methods
Animals and tissue preparation
ArKOmice were generated by targeted disruption of exons 1
and 2 of the Cyp 19 gene and consequently could not convert
androgens into estrogens (22). Heterozygous males and females
of the C57BL/6J strain were bred to generateWT, heterozygous,
and homozygous-null (ArKO) offspring at the Center for Cel-
lular and Molecular Neurobiology (now named GIGA Neuro-
sciences), University of Lie`ge, Lie`ge, Belgium. Food (phytoestro-
gen-free mouse chow D10001 AIN-76A; Brogaarden, Lynge,
Denmark) and water were available to mice ad libitum. To ob-
tain brain tissues at postnatal ages, pregnant females were
checked daily for parturition toward the end of pregnancy. Be-
cause all breeding females were housed under a 12-h light, 12-h
dark cycle (lights on between 0800 and 2000 h), parturition
usually occurred in the morning, 1–2 h after lights on. The day
of birth was designated as P0. Brain tissues were collected on P0,
P5, P10, P15, P20, and P25. We collected brains at these 5-d
intervals because neonatal estradiol has been shown to induce
hypothalamic PR expression in fewer than 5 days (15). Postnatal
mice were decapitated whereupon brains were rapidly removed
from the skull and immediately immersion fixed in 5% acrolein
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in 0.1 M PBS (pH 7.6) for 2.5 h, rinsed twice in PBS for 30 min,
and then cryoprotected in 30%sucrose andwhen sunken, frozen
on dry ice and stored at 80 C until being processed for PR
immunocytochemistry. The sex of each pup was determined by
visual inspection of the ano-genital distance, and the presence of
ovaries or testeswas confirmedby laparotomy.Todetermine the
genotype of the pup, the tail was kept and stored at 20 C for
later PCRanalysis ofDNA.The number of animals used for each
groupwasas follows: femaleWT,P08,P58,P108,P15
8, P20 8, and P25 8; female ArKO, P0 7, P5 7, P10
8, P15  8, P20  8, and P25  7; male WT, P0  6, P5  7,
P10 7, P15 8, P20 7, and P25 7; and male ArKO, P0
7, P5  9, P10  7, P15  8, P20  8, and P25  8.
Brain sections (30 m thick) were cut on a Leica CM3050S
cryostat. Forebrains were cut coronally from the level of the end of
the olfactory bulb. Sections were saved in three different series,
placed in antifreeze solution, and stored at 20 C for later
immunocytochemistry.
All experiments were conducted in accordance with the
guidelines set forth by the National Institutes of Health Guiding
Principles for the Care and Use of Research Animals and were
approved by the Committees for Ethical Animal Use at the Uni-
versity of Lie`ge and at Boston University.
Immunocytochemistry
Every effort was made to include an equal number of brains
from all 24 groups in each immunocytochemistry run. PR im-
munocytochemistrywas carriedout on free-floating sections.All
incubationswere carried out at room temperature (22C), and all
washes of brain tissue sections were performed using Tris-buff-
ered saline (TBS, 0.05 M) or TBS containing 0.2% Triton X-100
(TBST). Briefly, sections were rinsed and incubated in 10% so-
dium borohydride for 15 min. Endogenous peroxidase activity
was quenched by incubating the sections for 30 min with 3%
hydrogen peroxide. Aspecific binding sites were then blocked by
incubating sections for 30 min with 5% normal goat serum
(Dako Cytomation, Glostrup, Denmark). Sections were then
incubated with a rabbit polyclonal antibody (1/1000 in TBST-
normal goat serum 2%; Dako Cytomation) against the DNA-
binding domain of the human PR for 72 h at 4C. This antibody
detects both the A and B isoforms of PR (23) and has been
validated for specific staining of PR inmouse brain byWagner
et al. (21) and in the Bakker laboratory (unpublished results).
Sections were then incubated for 1 h in a goat antirabbit bi-
otinylated antibody (1:800 in TBST; Dako Cytomation). Sec-
tions were then incubated for 1 h in avidin-biotin complex
(Vector Laboratories, Burlingame, CA) and then reacted for 7
min with 3,3-diaminobenzidine tetrahydrochloride (DAB
kit; Vector). Sections were then washed, mounted onto gela-
tin-coated slices, dried overnight, and coverslipped with a
gelatin-based medium.
Image analysis and statistics
The relative amount of PR-ir was measured in three brain
areas (Fig. 1): the AVPv (Fig. 28 of the mouse atlas: interaural,
4.18mm; bregma, 0.38mm), the medial part of theMPOA (Fig.
30 of the mouse atlas: interaural, 3.94 mm; bregma, 0.14 mm),
and theVMH-L (Fig. 43 of themouse atlas: interaural, 2.34mm;
bregma, 1.46 mm) (24). PR-ir was quantified by an experi-
menter, who was blind to the sex/genotype of the mice, using
computer-assisted image analysis. Sections were digitized
through a video camera (CCD camera, XC-77CE, Sony) at-
tached to a microscope (Olympus MTV-3 with 20 objective),
and PR-irwas quantifiedwith a PC-based image analysis system
using the particle-counting protocol of the NIH Image pro-
gram (version 1.37; Wayne Rasband, National Institutes of
Health, Bethesda,MD). Digital images were made binary, and a
manual threshold was used for discriminating the labeled ma-
terial from the background. With a 20 objective, exclusion
thresholds were set at five (low threshold) and 200 (high thresh-
old) pixels to remove from the quantification dark objects that
were not the same size as a cell nucleus. The relative amount of
PR-ir in the AVPv, MPOA, and VMH-L was measured in one
entire field (720 480 pixels; area 328,769 m2) placed in a
standardized manner based on predefined anatomical land-
marks in the sections (e.g. edgeof the thirdventricle orprominent
fiber tracts) and determined by measuring the area (square mi-
crometers) covered by thresholded pixels [those pixels with a
gray level higher than a defined threshold density (specific im-
munoreactive staining)]. Threshold was determined as a con-
stant function of the background OD defined as the mean OD
three to five times the SD higher than the mean background den-
sity. The mean background density was measured in a region
devoid of PR-ir, immediately lateral to the analyzed region con-
taining PR-ir. We measured the relative amount of PR-ir in sec-
tions from the right hemisphere of each animal that included the
three selected brain regions.
Statistical analysiswasperformedusing a three-wayANOVA
[P  0.05; factors included age (six)  genotype (four)  sex
(two)], followed by planned pairwise comparisons using Fisher
least significant difference post hoc tests (P  0.05).
Results
Representative examples of PR-ir cells in the MPOA of
WT vs. ArKO female and male mice killed at P10 are
shown in Fig. 2. PR-ir first appeared in theMPOA ofWT
females at P10, and the levels of PR expression progres-
sively increased in WT females over P10–P25 (Fig. 3).
Over this prepubertal period, PR-irwas consistently lower
in ArKO females than in WT females. ANOVA revealed
a significant effect of genotype [F(1,154)  367.7; P 
0.0001], and post hoc comparisons showed that relative
amount of PR-ir was significantly lower (P  0.05) in
ArKO female than in WT female mice at each of the pre-
pubertal ages P15–P25. WT male mice consistently had
more PR-ir in the MPOA than WT females across the neo-
natal ages P0–P10. ANOVA revealed a significant effect of
sex [F(1,154)80.4;P0.0001], andpost hoc comparisons
revealed significant (P  0.05) differences between WT
male and WT female relative amount of PR-ir at P0–P10
but not at later ages. The relative amount of PR-ir in the
MPOA was consistently significantly (P 0.05) lower in
ArKO males than in WT males at all six postnatal ages
studied.
PR-ir first appeared in the AVPv ofWT females at P10,
and the levels of PR expression progressively increased in
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WT females over P10–P25 (Fig. 4). Over this prepubertal
period, PR-irwas consistently lower inArKOfemales than
in WT females. ANOVA revealed a significant effect of ge-
notype [F(1,150)148.1;P0.0001], and
post hoc comparisons showed that relative
amount of PR-ir was significantly lower
(P  0.05) in ArKO female than in WT
female mice at each of the ages P15–P25.
WTmalemice consistently hadmore PR-ir
in the AVPv than WT females across the
neonatal agesP0–P10.ANOVArevealeda
significant effectof sex [F(1,150)42.7;P
0.0001], and post hoc comparisons re-
vealedsignificant (P0.05)differencesbe-
tween WT male and WT female relative
amount of PR-ir at P0–P10 but not at later
ages. The relative amount of PR-ir in the
AVPv was consistently significantly (P 
0.05) lower in ArKO males than in WT
males at all six postnatal ages studied.
Therewas a progressive increase in the
relative amount of PR-ir in theVMH-Lof
both WT and ArKO female mice across
the postnatal ages sampled (Fig. 5), with
the values in ArKO females being lower
than inWT females only at P25. ANOVA
revealed a significant effect of genotype
[F(1,156)  101.4; P  0.0001], and post
hoc comparisons showed that relative
amount of PR-ir was significantly (P 
0.05) lower in ArKO females than inWT
females only at P25. There was much
more PR-ir in the VMH-L of WT males
than in WT females across the postnatal
ages P0–P20. ANOVA revealed a signif-
icant effect of sex [F(1,156)  81.8; P 
0.0001], and post hoc comparisons
showed that the relative amount of PR-ir
was significantly higher (P 0.05) in the
VMH-L of WT males than WT females
over P0–P20. Again, there was signifi-
cantly (P0.05) less PR-ir in theVMH-L
of ArKOmales thanWTmales across all
six postnatal ages sampled.Thus, the pat-
tern of PR-ir in the VMH-L was clearly
different from that observed for the
MPOA and AVPv.
Discussion
The present results support the view (12)
that estradiol contributes prepubertally
to at least one female-typical aspect of development in
both the MPOA and the AVPv, the expression of PR.
Thus, in WT female mice, we first detected PR-ir cells in
FIG. 1. Drawings taken from the mouse brain atlas of Paxinos and Franklin (24) showing
the location of forebrain regions in which PR-ir cells were quantified (shaded areas in each
panel) in the AVPv (A), MPOA (B). and VMH-L (C). The distance of each coronal brain slice
in front of () or behind () bregma is given for each panel.
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both of these brain regions at P10, and the levels of PR
expression steadily increased inWTfemaleskilledover the
ages P15–P25. Our observation that PR-ir values in both
the MPOA and the AVPv were significantly lower in
ArKO females than in WT females across the ages P15–
P25 suggests that estradiol normally stimulates PRexpres-
sion at these prepubertal ages inWT femalemice.Wagner
et al. (18) also first detectedPR-ir cells in theMPOAofWT
female mice killed at P8 (older ages were not studied), and
this level of PR expression was not different from that of
estradiol receptor (ER)- KO females. It is not known
whether PR expressionwould be reduced
in ER- KO female mice killed at later
postnatal ages (e.g. P10–P25). The re-
sults of several studies using female rats
further support our conclusion that es-
tradiol normally stimulates female-typi-
cal levels of prepubertal PR expression in
the mouse MPOA, although the exact
timingof estradiol’s postnatal actionmay
differbetween the twospecies.Thus,ovari-
ectomy shortly after birth significantly re-
duced PR-ir in the MPOA of female rats
killedatP13(14)oratP14(16). Inthe latter
study (16), administration of estradiol to
ovariectomized female rats significantly
augmented PR-ir in the MPOA across a
range (P7–P67) of postnatal ages. Also,
neonatal administration of an ER-, but
notanER-agonist, reliablystimulatedPR
expression in the MPOA of female rats
killed on P7 (25). Finally (20), transplacental administration
of the aromatase-blocking drug ATD significantly reduced
PR-ir present in the female ratMPOAat the endof gestation.
The traditional view is that female-typical aspects of
hypothalamic sexual differentiation in mammals occur
without the benefit of any active sex hormone signaling
(12). The present data from mice along with the rat data
cited above suggest, however, that the female-typical, pre-
pubertal profile of PR expression in the MPOA as well as
the AVPv depends on a stimulatory action of estradiol.
More research is needed to identify the sources
of this estradiol, which may include the fe-
males’ ovaries and/or de novo synthesis in the
female hypothalamus (20). Additional studies
are also needed to see whether the prepubertal
increase in neural PR expression seen in WT
females is simply a passive, inconsequential re-
sponse to increased ovarian production of es-
tradiol or, alternatively, whether long-lasting
morphological and/or behavioral neuroendo-
crine consequences of this prepubertal estro-
genic stimulation of PR expression can be iden-
tified in the female rodentMPOAandAVPv. A
feminizing role for estradiol has been reported
in the development of the sexually dimorphic
expression of kisspeptin (females more than
males), an important modulator of GnRH se-
cretion (11, 26). Both studies reported de-
creased numbers of kisspeptin neurons in the
rostral periventricular area of the third ventri-
cle, which includes the AVPv, in adult female
ArKOmice, even after treatmentwith estradiol
FIG. 2. Representative photomicrographs show coronal sections of the MPOA with PR-ir
cells in a WT female (A), an ArKO female (B), a WT male (C), and an ArKO male (D) at P10.
V, Third ventricle. Scale bar, 40 m.
FIG. 3. The relative amount (mean  SEM) of PR-ir in the MPOA on P0, P5, P10,
P15, P20, and P25 in male (M) and female (F) mice that were either WT or ArKO.
*, Post hoc comparisons indicated a significant (P  0.05) sex difference in WT mice
at the ages indicated. Post hoc comparisons also indicated significant (P  0.05)
differences between WT vs. ArKO females (F over brackets) and between WT and
ArKO males (M over brackets) at the ages shown.
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in adulthood (11). Clarkson et al. (26) also showed that
ovariectomy of female mice at P15 resulted in a 70–90%
reduction in kisspeptin expression within the rostral
periventricular area of the third ventricle analyzed at ei-
ther P30 or P60, whereas administration of 17-estradiol
to P15-ovariectomized mice from P15–P30 or P22–P30
completely restored kisspeptin expression in this brain
region. These results suggest that the sex difference in
kisspeptin neuronal number in WTmice re-
flects aprepubertal, organizational actionof
estradiol in females. Additional evidence of
an organizational role for prepubertal ovar-
ian hormones is the observation (27) that
ovariectomy on P20 reduced the later incor-
poration of newly born neurons into the fe-
male rat AVPv. More research is needed to
determinewhether any of these prepubertal,
organizational actionsof estradiolon thede-
veloping female nervous system are medi-
ated by the induction of PR and the concur-
rent effects of progesterone.
Compared with the timing of estradiol
action in the MPOA and AVPv, our results
suggest that there is a delay in the postnatal
age at which the female-typical profile of
VMH-L PR expression in mice depends on
the stimulatory action of estradiol. Thus, at
ages P0–P20, there were no differences in
PR-ir cell number between WT and ArKO
females; only at P25 was PR-ir cell number
significantly lower in ArKO than in WT fe-
males. Results obtained in rats (16) point to a similar,
albeit shorter, delay in the postnatal age when estradiol
first stimulates PRexpression in the femaleVMH-L.Thus,
ovariectomyonP0 failed to reducePR-ir cell number in the
VMH-L of female rats killed on P4, and administering
estradiol to neonatally ovariectomized females failed to
stimulate PR expression at P7, whereas significant estra-
diol-induced PR expression was seen over ages P14–P67.
In another study (25), administration of a
specific ER- agonist on P5 and P6was even
more effective than estradiol in stimulating
PR-ir cell number in the VMH-L of female
rats killed at P7. Furthermore, concurrent
administration of an ER- agonist together
with the ER- agonist reduced the stimula-
tion of PR expression on P7 otherwise ob-
tained by administering the ER- agonist
alone, suggesting that an early neonatal pe-
riod exists when ER- activation inhibits
ER--induced transcriptional activity. After
an initial neonatal delay in both female rats
andmice, estradiol, acting via ER-, reliably
stimulates PR expression in the VMH-L
across the life span. At the age of puberty,
this estradiol-stimulated expression of PR in
the VMH contributes importantly to the in-
duction of proceptive and receptive aspects
of feminine mating behaviors shown in re-
sponse to progesterone (28). Ovarian ste-
roids are thought to stimulate sexual recep-
FIG. 4. The relative amount (mean  SEM) of PR-ir in the AVPv on P0, P5, P10, P15,
P20, and P25 in male (M) and female (F) mice that were either WT or ArKO. *, Post hoc
comparisons indicated a significant (P  0.05) sex difference in WT mice at the ages
indicated. Post hoc comparisons also indicated significant (P  0.05) differences in WT
vs. ArKO females (F over brackets) and between WT and ArKO males (M over brackets)
at the ages shown.
FIG. 5. The relative amount (mean  SEM) of PR-ir in the VMH-L on P0, P5, P10, P15,
P20, and P25 in male (M) and female (F) mice that were either WT or ArKO. *, Post hoc
comparisons indicated a significant (P  0.05) sex difference in WT mice at the ages
indicated. Post hoc comparisons also indicated significant (P  0.05) differences in WT
vs. ArKO females (F over brackets) and between WT and ArKO males (M over brackets)
at the ages shown.
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tivity (lordosis) in female rodents by acting in the VMH-L
(28). The observation (10) thatArKOfemalemice showed
significantly less lordosis behavior than WT control fe-
males after ovariectomy, and treatmentwith estradiol and
progesterone in adulthood is correlated with the present
observation that PR expression was significantly reduced
at least at one prepubertal age (P25). Again,more research
is needed to determine whether a causal link exists be-
tween the absence of an estradiol-induced stimulation of
PR expression (with a resultant loss of responsiveness to
progesterone) in the VMH-L on or after P25 in ArKO
females and their laterbehavioral refractoriness toovarian
hormones.
The present results confirm and extend to P10 a pre-
vious report (18) that PR-ir cell number was significantly
greater in both the MPOA and VMH-L of WT male than
WT female mice killed at P0, P4, and P8. A similar sex
difference in PR expression in theMPOA across perinatal
ages was also reported in the rat (15, 29). Another report
from that group (21) showed that the organizational ef-
fects of testicular hormone (presumably testosterone), as
opposed to genes expressed directly off the sex chromo-
somes, stimulate increased expression of PR neonatally in
the MPOA and VMH-L of male vs. female mice. Indeed,
castration of male rats on the day of birth significantly
reduced PR expression in theMPOA over the next several
days (19).Many of the perinatal actions of testosterone in
the male rodent hypothalamus depend on the neural aro-
matization of this androgen into estradiol and the subse-
quent activation of ER- and/or - (1). Our observation
that PR-ir in the MPOA, AVPv, and VMH-L was signif-
icantly lower in ArKO males than in WT males across a
range of postnatal ages (P0–P25) suggests that estrogenic
metabolites of testosterone play an essential role in estab-
lishing the male-typical profile of hypothalamic PR ex-
pression in neonatal mice. A similar conclusion can be
drawn from the report (18) that PR-ir values in both the
MPOAandVMH-Lwere significantly lower inmalemice
with a null mutation of ER- than in WT males killed at
P0, P4, and P8. Likewise, transplacental administration of
the aromatase blocker ATD significantly attenuated PR
expression in the MPOA and AVPv of male rats killed at
the end of gestation (15). Taken together, these results for
mice and rats strongly suggest that themale-typical profile
of PR expression in bothMPOA and VMH-L depends on
the stimulatory action of estradiol formed via the neural
aromatization of testosterone secreted perinatally by the
testes.
Just as it is unknown whether prepubertal estradiol-in-
duced expression of hypothalamic PR expression contrib-
utes in the long term to female-typical brain and behavioral
differentiation, it is uncertain whether the increased neo-
natal expression of PR in the male rodent MPOA, AVPv,
and/orVMH-Lcontributes to the testosterone-dependent,
male-typical organization of brain and behavior. It has
been reported (14) that neonatal treatment of female rats
with thePRantagonistRU486 significantly attenuated the
masculinizing effect of neonatal testosterone on the vol-
ume of the sexually dimorphic nucleus of the POA,
whereas in another study (30), neonatal RU486 signifi-
cantly reduced the proportion of male rats that showed
mounting behavior in adult tests with an estrous female
rat. Interpretation of these results is complicated by the
fact the RU486 antagonizes glucocorticoid receptors in
addition to PR (31). Also, other studies (32, 33) revealed
either no significant disruptionor an enhancement ofmas-
culine sexual behavior in PRKO male mice. Likewise,
there was no disruption of normal male-male aggressive
behavior in PRKOmales (34). More research is needed to
determine whether other male-typical as well as female-
typical aspects of brain, behavioral, and/or reproductive
neuroendocrine sexual differentiation are disrupted in
PRKO mice of either sex.
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